| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3435851 | American Journal of Obstetrics and Gynecology | 2010 | 8 Pages |
Abstract
The glycolytic phenotype of ovarian cancer cells can be targeted for therapeutic intervention. Combined treatment modalities that target multiple cellular pathways hold promise for the treatment of chemoresistant ovarian cancer cells.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Paul MD, Heather BA, Malti MD, Gabrielle MD, Kent MPH, MS, J. Rebecca MD,